Respironics expands drug delivery operations
PARSIPPANY, N.J. – Respironics has opened a new U.S. headquarters for its Respiratory Drug Delivery (RDD) business, the company announced Dec. 10. The move doubles the size of its previous site in Cedar Grove, NJ. The new 26,000-square-foot facility houses the company’s RDD management, marketing, sales, operations management and product development teams. For fiscal 2007, Respironics RDD business generated $62.2 million, a 16% increase.